# Neoadjuvant Chemotherapy Versus Surgery Alone for Esophageal Squamous Cell Carcinoma

> **NCT02395705** · PHASE3 · COMPLETED · sponsor: **Henan Cancer Hospital** · enrollment: 528 (estimated)

## Conditions studied

- Esophageal Neoplasm

## Interventions

- **DRUG:** cisplatin and paclitaxel

## Key facts

- **NCT ID:** NCT02395705
- **Lead sponsor:** Henan Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2022-10
- **Final completion:** 2022-10
- **Target enrollment:** 528 (ESTIMATED)
- **Last updated:** 2022-10-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02395705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02395705, "Neoadjuvant Chemotherapy Versus Surgery Alone for Esophageal Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02395705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*